The DOI matches its Crossref record; 32 of the 34 references it cites were found in a registry or an index.
MDS clinical diagnostic criteria for Parkinson’s disease
Abstract
This document presents the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's disease (PD). The Movement Disorder Society PD Criteria are intended for use in clinical research but also may be used to guide clinical diagnosis. The benchmark for these criteria is expert clinical diagnosis; the criteria aim to systematize the diagnostic process, to make it reproducible across centers and applicable by clinicians with less expertise in PD diagnosis. Although motor abnormalities remain central, increasing recognition has been given to nonmotor manifestations; these are incorporated into both the current criteria and particularly into separate criteria for prodromal PD. Similar to previous criteria, the Movement Disorder Society PD Criteria retain motor parkinsonism as the core feature of the disease, defined as bradykinesia plus rest tremor or rigidity. Explicit instructions for defining these cardinal features are included. After documentation of parkinsonism, determination of PD as the cause of parkinsonism relies on three categories of diagnostic features: absolute exclusion criteria (which rule out PD), red flags (which must be counterbalanced by additional supportive criteria to allow diagnosis of PD), and supportive criteria (positive features that increase confidence of the PD diagnosis). Two levels of certainty are delineated: clinically established PD (maximizing specificity at the expense of reduced sensitivity) and probable PD (which balances sensitivity and specificity). The Movement Disorder Society criteria retain elements proven valuable in previous criteria and omit aspects that are no longer justified, thereby encapsulating diagnosis according to current knowledge. As understanding of PD expands, the Movement Disorder Society criteria will need continuous revision to accommodate these advances. © 2015 International Parkinson and Movement Disorder Society
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PD was diagnosed by two neurologists according to Postuma et al., criteria. 4”
From Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients (2020) · cites this paper as [4]
In the citing paper
“Final diagnoses were based on internationally established criteria [12, 46, 49–52].”
In the citing paper
“PD is the second most common neurodegenerative disorder and is defined by the presence of motor symptoms including bradykinesia, rigidity, and resting tremor (Postuma et al., 2015).”
From Microbiome–microglia connections via the gut–brain axis (2019) · cites this paper as Postuma et al., 2015
In the citing paper
“The final diagnosis of PD, MSA, and PSP was determined by two neurologists according to the updated clinical guidelines[37-40].”
From QEEG Signatures are Associated with Nonmotor Dysfunctions in Parkinson's Disease and Atypical Parkinsonism: An Integrative Analysis (2023) · cites this paper as [39]
In the citing paper
“PD patients present with tremors, bradykinesia and rigidity, with atrophy initially observed in the substantial nigra and brainstem, progressing to the basal ganglia and related subcortical regions over the course of the disease (Postuma et al., 2015).”
From Thinking versus feeling: How interoception and cognition influence emotion recognition in behavioural-variant frontotemporal dementia, Alzheimer's disease, and Parkinson's disease (2023) · cites this paper as Postuma et al., 2015
In the citing paper
“Diagnosis was established by the multidisciplinary teams at each research institute based on current consensus diagnostic criteria (McKhann et al., 2011; Postuma et al., 2015; Rascovsky et al., 2011).”
From Thinking versus feeling: How interoception and cognition influence emotion recognition in behavioural-variant frontotemporal dementia, Alzheimer's disease, and Parkinson's disease (2023) · cites this paper as Postuma et al., 2015
Citations
Cites
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders · doi:10.1002/mds.22340 · Cited by 7,536
Self-citationSensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationThe relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Second consensus statement on the diagnosis of multiple system atrophy
Gilman, S., Wenning, G. K., Low, P. A., Brooks, D. J., Mathias, C. J., Trojanowski, J. Q., Wood, N. W., Colosimo, C., Dürr, A., Fowler, C. J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000324625.00404.15 · Cited by 3,140
Self-citationDiagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
MDS research criteria for prodromal Parkinson's disease
Berg, D., Postuma, R. B., Adler, C. H., Bloem, B. R., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G. M., Joseph, L., et al. (2015) · Movement Disorders · doi:10.1002/mds.26431 · Cited by 1,394
Self-citationThe accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service
Hughes, A. J., Daniel, S. E., Ben‐Shlomo, Y., & Lees, A. J. (2002) · Brain · doi:10.1093/brain/awf080 · Cited by 1,258
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
Litvan, I., Bhatia, K. P., Burn, D. J., Goetz, C. G., Lang, A. E., McKeith, I. G., Quinn, N. P., Sethi, K. D., Shults, C. W., & Wenning, G. K. (2003) · Movement Disorders · doi:10.1002/mds.10459 · Cited by 1,011
Self-citation
Flagged first, then by citations
2 of the 34 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 1,020
Approaches to Disease Modification for Parkinson's Disease: Clinical Trials and Lessons Learned
Hung, A. Y., & Schwarzschild, M. A. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00964-w · Cited by 53
Papadopoulos, A., Iakovakis, D., Klingelhoefer, L., Bostantjopoulou, S., Chaudhuri, К. R., Kyritsis, K., Hadjidimitriou, S., Charisis, V. S., Hadjileontiadis, L. J., & Delopoulos, A. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-78418-8 · Cited by 52
Kleiner, G., Fernandez, H. H., Chou, K. L., Fasano, A. A., Duque, K. R., Hengartner, D., Law, A., Margolius, A. J., Poon, Y., Sáenz‐Farret, M., et al. (2021) · Movement Disorders · doi:10.1002/mds.28507 · Cited by 52
Suzuki, K., Numao, A., Komagamine, T., Haruyama, Y., Kawasaki, A., Funakoshi, K., Fujita, H., Suzuki, S., Okamura, M., Shiina, T., et al. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212560 · Cited by 52
Prodromal Dementia With Lewy Bodies: Evolution of Symptoms and Predictors of Dementia Onset
Wyman‐Chick, K. A., O'Keefe, L. R., Weintraub, D. A., Armstrong, M. J., Rosenbloom, M. H., Martin, P. K., Barclay, T. R., & Barrett, M. J. (2021) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887211023586 · Cited by 52
Neuroprotective Trials in REM Sleep Behavior Disorder
Postuma, R. B. (2022) · Neurology · doi:10.1212/wnl.0000000000200235 · Cited by 52
Self-citationLees, A. J., TOLOSA, E. S., Stocchi, F., Ferreira, J. J., Rascol, O., Antonini, A., & Poewe, W. H. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2176220 · Cited by 52
Self-citationPeña‐Díaz, S., García‐Pardo, J., & Ventura, S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030839 · Cited by 54
Bräuer, S., Rossi, M., Sajapin, J., Henle, T., Gasser, T., Parchi, P., Brockmann, K., & Falkenburger, B. H. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01653-3 · Cited by 52
Self-citationDemailly, A., Moreau, C., & Devos, D. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230372 · Cited by 52
ACTUALIZACIÓN EN LA ENFERMEDAD DE PARKINSON
Martínez‐Fernández, R., Gasca‐Salas, C., Sánchez‐Ferro, Á., & Obeso, J. A. (2016) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2016.06.010 · Cited by 52
Self-citationScorza, F. A., do Carmo, A. C., FIORINI, A. C., Nejm, M. B., Scorza, C. A., Finsterer, J., & Ferraz, H. B. (2017) · Clinics · doi:10.6061/clinics/2017(11)01 · Cited by 52
Effect of istradefylline on mood disorders in Parkinson's disease
Nagayama, H., Kano, O., Murakami, H., Ono, K., Hamada, M., Toda, T., Sengoku, R., Shimo, Y., & Hattori, N. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.11.005 · Cited by 52
Patients' views on the ethical challenges of early Parkinson disease detection
Schaeffer, E., Rogge, A., Nieding, K., Helmker, V., Letsch, C., Hauptmann, B., & Berg, D. (2020) · Neurology · doi:10.1212/wnl.0000000000009400 · Cited by 49
Self-citationParkinson's disease: Current drug therapy and unraveling the prospects of nanoparticles
Paul, A., & Yadav, K. S. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101790 · Cited by 52
Effects of safinamide on pain in Parkinson’s disease with motor fluctuations: an exploratory study
Geroin, C., Vico, I. A. D., Squintani, G. M., Segatti, A., Bovi, T., & Tinazzi, M. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02218-7 · Cited by 52
Machine learning discriminates a movement disorder in a zebrafish model of Parkinson's disease
Hughes, G. L., Lones, M. A., Bedder, M., Currie, P. D., Smith, S. L., & Pownall, M. E. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.045815 · Cited by 52
Multiple comorbid sleep disorders adversely affect quality of life in Parkinson’s disease patients
Zhang, Y., Zhao, J., Huang, D., Chen, W., Yuan, C. X., Li, J., Wang, Y. H., Jin, L. J., Lu, L., Wang, X., et al. (2020) · npj Parkinson s Disease · doi:10.1038/s41531-020-00126-x · Cited by 52
Targeted sequencing of Parkinson’s disease loci genes highlights SYT11, FGF20 and other associations
Rudakou, U., Yu, E., Krohn, L., Ruskey, J. A., Asayesh, F., Dauvilliers, Y. A., Spiegelman, D., Greenbaum, L., Fahn, S., Waters, C., et al. (2020) · Brain · doi:10.1093/brain/awaa401 · Cited by 55
Increased Risk of Parkinson's Disease in Patients With Schizophrenia Spectrum Disorders
Kuusimäki, T., Al‐Abdulrasul, H., Kurki, S. H., Hietala, J. A., Hartikainen, S. A., Koponen, M., Tolppanen, A., & Kaasinen, V. (2021) · Movement Disorders · doi:10.1002/mds.28484 · Cited by 55
Functional Connectomics and Disease Progression in Drug‐Naïve Parkinson's Disease Patients
Micco, R. D., Agosta, F., Basaia, S., Siciliano, M., Cividini, C., Tedeschi, G., Filippi, M., & Tessitore, A. (2021) · Movement Disorders · doi:10.1002/mds.28541 · Cited by 53
A six-metabolite panel as potential blood-based biomarkers for Parkinson’s disease
Klatt, S., Doecke, J. D., Roberts, A., Boughton, B. A., Masters, C. L., Horne, M. K., & Roberts, B. R. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00239-x · Cited by 51
Mancini, M., Afshari, M., Almeida, Q. J., Huffmaster, S. L. A., Balfany, K., Camicioli, R. M., Christiansen, C. L., Dale, M. L., Dibble, L. E., Earhart, G. M., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00897-1 · Cited by 52
The biomarkers of immune dysregulation and inflammation response in Parkinson disease
Chen, L., Mo, M., Li, G., Cen, L., Wei, L., Xiao, Y., Chen, X., Li, S., Yang, X., Qu, S., et al. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0063-3 · Cited by 51
Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson's disease
Maass, F., Michalke, B., Leha, A., Boerger, M., Zerr, I., Koch, J. C., Tönges, L., Bähr, M., & Lingor, P. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14316 · Cited by 51
Dong, M.-X., Feng, X., Xu, X., Hu, L., Liu, Y., Jia, S., Li, B., Chen, W., & Wei, Y. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00257 · Cited by 51
Association of GALC, ZNF184, IL1R2 and ELOVL7 With Parkinson’s Disease in Southern Chinese
Li, G., Cui, S., Du, J., Liu, J., Zhang, P., Fu, Y., He, Y., Zhou, H., Ma, J., & Chen, S. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00402 · Cited by 51
Neuropsychological, electrophysiological, and neuroimaging biomarkers for REM behavior disorder
Ferini‐Strambi, L., Fasiello, E., Sforza, M., Salsone, M., & Galbiati, A. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1640603 · Cited by 51
Scherbaum, R., Hartelt, E., Kinkel, M., Gold, R., Muhlack, S., & Tönges, L. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09657-7 · Cited by 54
The Quebec Parkinson Network: A Researcher-Patient Matching Platform and Multimodal Biorepository
Gan‐Or, Z., Rao, T., Léveillé, E., Degroot, C., Chouinard, S., Cicchetti, F., Dagher, A., Das, S., Désautels, A., Drouin‐Ouellet, J., et al. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191775 · Cited by 56
Self-citationRovini, E., Maremmani, C., & Cavallo, F. (2020) · Sensors · doi:10.3390/s20092630 · Cited by 51
Tamplin, J., Morris, M. E., Marigliani, C., Baker, F. A., Noffs, G., & Vogel, A. P. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191838 · Cited by 51
Accuracy of Smartphone Video for Contactless Measurement of Hand Tremor Frequency
Williams, S., Fang, H., Relton, S. D., Wong, D., Alam, T., & Alty, J. (2020) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13119 · Cited by 50
Garofalo, M., Pandini, C., Bordoni, M., Pansarasa, O., Rey, F., Costa, A. C., Minafra, B., Diamanti, L., Zucca, S., Carelli, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249500 · Cited by 54
Cilia, R., Piatti, M., Cereda, E., Bolliri, C., Caronni, S., Ferri, V., Cassani, E., Bonvegna, S., Ferrarese, C., Zecchinelli, A., et al. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202297 · Cited by 51
Early changes of fecal short‐chain fatty acid levels in patients with mild cognitive impairments
Gao, C., Li, B., He, Y., Huang, P., Du, J., He, G., Zhang, P., Tang, H., & Chen, S. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14252 · Cited by 50
Clinical Diagnostic Accuracy of Early/Advanced Parkinson Disease
Adler, C. H., Beach, T. G., Zhang, N., Shill, H. A., Driver‐Dunckley, E. D., Mehta, S. H., Atri, A., Caviness, J. N., Serrano, G. E., Shprecher, D., et al. (2020) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000001016 · Cited by 53
Self-citationWood, K. H., Memon, A. A., Memon, R. A., Joop, A., Pilkington, J., Catiul, C., Gerstenecker, A., Triebel, K., Cutter, G., Bamman, M. M., et al. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202215 · Cited by 55
Kang, J. J., Chen, Y., Xu, G. D., Bao, S., Wang, J., Ge, M., Shen, L., & Jia, Z. Z. (2022) · European Radiology · doi:10.1007/s00330-022-08790-8 · Cited by 50
Dynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late Stage
Du, G., Wang, E., Sica, C. T., Chen, H., Jesus, S. D., Lewis, M. M., Kong, L., Connor, J. R., Mailman, R. B., & Huang, X. (2022) · Movement Disorders · doi:10.1002/mds.29062 · Cited by 51
Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease
Fu, Y., Zhou, L., Li, H., Hsiao, J.-H. T., Li, B., Tanglay, O., Auwyang, A. D., Wang, E., Feng, J., Kim, W. S., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02488-3 · Cited by 52
Self-citationDam, T., Pagano, G., Brumm, M. C., Gochanour, C., Poston, K. L., Weintraub, D. A., Chahine, L. M., Coffey, C. S., Tanner, C. M., Kopil, C., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00789-w · Cited by 50
Self-citationFiorenzato, E., Cauzzo, S., Weis, L., Garon, M., Pistonesi, F., Cianci, V., Nasi, M. L., Vianello, F., Zecchinelli, A., Pezzoli, G., et al. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123283 · Cited by 50
Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages
Moreira, R. C., Zonta, M. B., de Araújo, A. P. S., Israel, V. L., & Teive, H. A. G. (2017) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20170091 · Cited by 48
Kim, D. H., Wit, H., & Thurston, M. (2018) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000890 · Cited by 49
Parkinsonism Relating to Intoxication with Glyphosate
Eriguchi, M., Iida, K., Ikeda, S., Osoegawa, M., Nishioka, K., Hattori, N., Nagayama, H., & Hara, H. (2019) · Internal Medicine · doi:10.2169/internalmedicine.2028-18 · Cited by 50
Dayan, E., & Browner, N. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.08.003 · Cited by 49
Chen, Y., Gu, X., Ou, R., Zhang, L., Hou, Y., Liu, K., Cao, B., Wei, Q., Li, C., Song, W., et al. (2020) · Movement Disorders · doi:10.1002/mds.28191 · Cited by 50
Molecular Imaging Approaches in Dementia
Villemagne, V. L., Barkhof, F., Garibotto, V., Landau, S. M., Nordberg, A. K., & van Berckel, B. N. M. (2021) · Radiology · doi:10.1148/radiol.2020200028 · Cited by 56
PD-ResNet for Classification of Parkinson’s Disease From Gait
Yang, X., Ye, Q., Cai, G., Wang, Y.-Q., & Cai, G. (2022) · IEEE Journal of Translational Engineering in Health and Medicine · doi:10.1109/jtehm.2022.3180933 · Cited by 57
Liu, W., Tung, T., Zhang, C., & Shi, L. (2022) · Brain and Behavior · doi:10.1002/brb3.2690 · Cited by 55
A Review on the Clinical Diagnosis of Multiple System Atrophy
Stanković, I., Fanciulli, A., Sidoroff, V., & Wenning, G. K. (2022) · The Cerebellum · doi:10.1007/s12311-022-01453-w · Cited by 54
Yu, R., & Wu, R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.943438 · Cited by 49
Meloni, M., Agliardi, C., Guerini, F. R., Zanzottera, M., Bolognesi, E., Picciolini, S., Marano, M., Magliozzi, A., Fonzo, A. D., Arighi, A., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105947 · Cited by 52
Huang, W., Xu, W., Wan, R., Zhang, P., Zha, Y., & Pang, M. (2023) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2023.3239780 · Cited by 54
Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid
Beyer, M. P., Videla, L. A., Farías, C., & Valenzuela, R. (2023) · Nutrients · doi:10.3390/nu15153317 · Cited by 54
Neurological Insights into Sleep Disorders in Parkinson’s Disease
Thangaleela, S., Sivamaruthi, B. S., Kesika, P., Mariappan, S., Rashmi, S., Choeisoongnern, T., Sittiprapaporn, P., & Chaiyasut, C. (2023) · Brain Sciences · doi:10.3390/brainsci13081202 · Cited by 55
Pasławski, W., Khosousi, S., Hertz, E., Markaki, I., Boxer, A. L., & Svenningsson, P. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00374-w · Cited by 57
Arnaldi, D., Mattioli, P., Raffa, S., Pardini, M., Massa, F., Iranzo, Á., Perissinotti, A., Niñerola‐Baizán, A., Gaig, C., Serradell, M., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26902 · Cited by 49
Is PIGD a legitimate motor subtype in Parkinson disease?
Kotagal, V. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.312 · Cited by 49
Insomnia and somnolence in idiopathic RBD: a prospective cohort study
Postuma, R. B., Gagnon, J., Pelletier, A., & Montplaisir, J. Y. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-017-0011-7 · Cited by 56
Self-citationTypical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2
Boot, E., Butcher, N. J., Udow, S. J., Marras, C., Mok, K. Y., Kaneko, S., Barrett, M. J., Prontera, P., Berman, B. D., Masellis, M., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005660 · Cited by 49
Self-citationGuerra, A., Bologna, M., Paparella, G., Suppa, A., Colella, D., Lazzaro, V. D., Brown, P., & Berardelli, A. (2018) · Neural Plasticity · doi:10.1155/2018/4593095 · Cited by 49
Clinical Features and Correlates of Excessive Daytime Sleepiness in Parkinson's Disease
Xiang, Y., Xu, Q., Sun, Q., Wang, Z., Tian, Y., Fang, L., Yang, Y., Tan, J., Yan, X., Tang, B., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00121 · Cited by 52
Cerebrospinal Fluid and Plasma Biomarkers in Neurodegenerative Diseases
Seino, Y., Nakamura, T., Kawarabayashi, T., Hirohata, M., Narita, S., Wakasaya, Y., Kaito, K., Ueda, T., Harigaya, Y., & Shoji, M. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181152 · Cited by 50
Updates and advances in the treatment of Parkinson disease
Hayes, M. W., Fung, V. S. C., Kimber, T. E., & O’Sullivan, J. D. (2019) · The Medical Journal of Australia · doi:10.5694/mja2.50224 · Cited by 49
Niemann, N., Billnitzer, A., & Jankovic, J. J. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.11.017 · Cited by 50
Parkinson mice show functional and molecular changes in the gut long before motoric disease onset
Gries, M., Christmann, A., Schulte, S., Weyland, M., Rommel, S., Martin, M., Baller, M. K., Röth, R., Schmitteckert, S., Unger, M. M., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00439-2 · Cited by 55
Orthostatic Hypotension Is Associated With Cognitive Decline in Parkinson Disease
Longardner, K., Bayram, E., & Litvan, I. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00897 · Cited by 48
Self-citationZhuang, S., Wang, F., Gu, X., Wu, J., Mao, C., Gui, H., Chen, J., & Liu, C. (2020) · Parkinson s Disease · doi:10.1155/2020/7295414 · Cited by 48
Bibliometric Evaluation of Global Tai Chi Research from 1980–2020
You, Y., Min, L., Tang, M., Chen, Y., & Ma, X. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18116150 · Cited by 52
Reaching and Grasping Movements in Parkinson’s Disease: A Review
Fasano, A., Mazzoni, A., & Falotico, E. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-213082 · Cited by 48
Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease
Bianchini, E., Onelli, C., Morabito, C., Alborghetti, M., Rinaldi, D., Anibaldi, P., Marcolongo, A., Salvetti, M., & Pontieri, F. E. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.909197 · Cited by 48
Li, J., Zhao, J., Chen, L., Gao, H., Zhang, J., Wang, D., Zou, Y., Qin, Q., Qu, Y., Li, J., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.023 · Cited by 52
Kuzkina, A., Panzer, C., Seger, A., Schmitt, D., Rößle, J., Schreglmann, S. R., Knacke, H., Salabasidou, E., Kohl, A., Sittig, E., et al. (2023) · Movement Disorders · doi:10.1002/mds.29340 · Cited by 49
Self-citationEye movements in Parkinson’s disease: from neurophysiological mechanisms to diagnostic tools
Antoniades, C. A., & Spering, M. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.11.001 · Cited by 52
Parkinson’s disease diagnosis using deep learning: A bibliometric analysis and literature review
Abumalloh, R. A., Nilashi, M., Samad, S., Ahmadi, H., Alghamdi, A., Alrizq, M., & AlYami, S. S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102285 · Cited by 51
Freezing of Gait in Parkinson's Disease: Its Pathophysiology and Pragmatic Approaches to Management
Iansek, R., & Danoudis, M. E. (2016) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12463 · Cited by 48
Redenšek, S., Trošt, M., & Dolžan, V. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00020 · Cited by 48
Structural and functional alterations of the heart in Parkinson’s disease
Piqueras‐Flores, J., López-García, A., Moreno-Reig, Á., González‐Martínez, A., Hernández-González, A., Vaamonde‐Gamo, J., & y, A. J.-R. (2017) · Neurological Research · doi:10.1080/01616412.2017.1390933 · Cited by 48
Wang, J., Huang, Z., Li, Y., Ye, F., Wang, C., Zhang, Y., Cheng, X., Fei, G., Liu, K., Zeng, M., et al. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.07.007 · Cited by 48
Gao, C., Smith, S. L., Lones, M. A., Jamieson, S., Alty, J., Cosgrove, J., Zhang, P., Liu, J., Chen, Y., Du, J., et al. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0124-x · Cited by 48
Guo, X., Shan, C., Hou, Y., Zhu, G., Tao, B., Sun, L., Zhao, H., Ning, G., Li, S., & Liu, J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00343 · Cited by 50
Nigrosome 1 imaging: technical considerations and clinical applications
Kim, E. Y., Sung, Y. H., & Lee, J. (2019) · British Journal of Radiology · doi:10.1259/bjr.20180842 · Cited by 48
Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein
Xu, M., Ryan, P., Rudrawar, S., Quinn, R. J., Zhang, H., & Mellick, G. D. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0304-y · Cited by 49
Journal of Neurochemistry: Issue Information
Correia-Guedes, L., Mestre, T., Outeiro, T., & Ferreira, J. J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14902 · Cited by 30
Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside
Wang, M., Ling, K., Tan, J. J., & Lu, C. (2020) · Cells · doi:10.3390/cells9061489 · Cited by 50
The continuum between neurodegeneration, brain plasticity, and movement: a critical appraisal
Schirinzi, T., Canevelli, M., Suppa, A., Bologna, M., & Marsili, L. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0011 · Cited by 50
Talitckii, A., Kovalenko, E., Anikina, A., Zimniakova, O., Semenov, M., Витальевна, Б. Е., Shcherbak, A., Dylov, D. V., & Somov, A. (2020) · IEEE Sensors Journal · doi:10.1109/jsen.2020.3027564 · Cited by 50
Yasaka, K., Kamagata, K., Ogawa, T., Hatano, T., Takeshige‐Amano, H., Ogaki, K., Andica, C., Akai, H., Kunimatsu, A., Uchida, W., et al. (2021) · Neuroradiology · doi:10.1007/s00234-021-02648-4 · Cited by 51
Simple Smartphone-Based Assessment of Gait Characteristics in Parkinson Disease: Validation Study
Su, D., Liu, Z., Jiang, X., Zhang, F., Yu, W., Ma, H., Wang, C., Wang, Z., Wang, X., Hu, W., et al. (2021) · JMIR mhealth and uhealth · doi:10.2196/25451 · Cited by 48
Review of Metabolomics-Based Biomarker Research for Parkinson’s Disease
Li, X., Fan, X., Yang, H., & Liu, Y. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02657-7 · Cited by 47
Motor Cortical Network Excitability in Parkinson's Disease
Leodori, G., Bartolo, M. I. D., Guerra, A., Fabbrini, A., Rocchi, L., Latorre, A., Paparella, G., Belvisi, D., Conte, A., Bhatia, K. P., et al. (2022) · Movement Disorders · doi:10.1002/mds.28914 · Cited by 47
The Effect of Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study
Donadio, V., Incensi, A., Rizzo, G., Fileccia, E., Ventruto, F., Riva, A., Tiso, D., Recchia, M., Vacchiano, V., Infante, R., et al. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac034 · Cited by 47
DAT and TH expression marks human Parkinson’s disease in peripheral immune cells
Gopinath, A., Mackie, P. M., Hashimi, B., Buchanan, A. M., Smith, A. R., Bouchard, R. S., Shaw, G., Badov, M., Saadatpour, L., Gittis, A. H., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00333-8 · Cited by 47
Baseline characteristics of the North American prodromal Synucleinopathy cohort
Elliott, J. E., Lim, M. M., Keil, A. T., Postuma, R. B., Pelletier, A., Gagnon, J., Louis, E. K. S., Forsberg, L. K., Fields, J. A., Huddleston, D. E., et al. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51738 · Cited by 47
Self-citationHuang, Y., Chaturvedi, K., Nayan, A.-A., Hesamian, M. H., Braytee, A., & Prasad, M. (2024) · Information · doi:10.3390/info15040220 · Cited by 47
Acupuncture and Sleep Quality Among Patients With Parkinson Disease
Yan, M., Fan, J., Liu, X., Li, Y., Wang, Y., Tan, W., Chen, Y., He, J., & Zhuang, L. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.17862 · Cited by 49
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease
Barba, L., Abu‐Rumeileh, S., Barthel, H., Massa, F., Foschi, M., Bellomo, G., Gaetani, L., Thal, D. R., Parnetti, L., & Otto, M. (2024) · Brain · doi:10.1093/brain/awae203 · Cited by 52
Digital biomarkers for non-motor symptoms in Parkinson’s disease: the state of the art
Daalen, J. M. J., van den Bergh, R., Prins, E. M., Moghadam, M. S. C., van den Heuvel, R., Veen, J., Mathur, S., Meijerink, H., Mirelman, A., Darweesh, S. K. L., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01144-2 · Cited by 52
Self-citation
Metadata
- Authors
- Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., Halliday, G., Goetz, C. G., Gasser, T., Dubois, B., Chan, P., Bloem, B. R., Adler, C. H., & Deuschl, G.
- Affiliations
- Montreal General Hospital (CA)
- German Center for Neurodegenerative Diseases (DE)
- University of Pennsylvania Health System (US)
- Innsbruck Medical University (AT)
- Mount Sinai Hospital (US)
- Philipps University of Marburg (DE)
- University of Navarra‐FIMA Pamplona Spain
- Institute for Neurodegenerative Disorders (US)
- University of California San Diego (US)
- Toronto Western Hospital (CA)
- Neuroscience Research Australia (AU)
- Rush University Medical Center (US)
- Pitié-Salpêtrière Hospital (FR)
- Xuan Wu Hospital of the Capital Medical University (CN)
- Radboud University Nijmegen (NL)
- Mayo Clinic in Arizona (US)
- Christian-Albrechts-Universität zu Kiel (DE)
- Corresponding author
- Postuma, Ronald B.
- Berg, Daniela
- ORCID
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2015-10
- Volume
- 30
- Issue
- 12
- Pages
- 1591-1601
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2112455323
- Cited by
- 7,653
- References
- 34
- Citations by year
- 2026: 1094 · 2025: 1265 · 2024: 1053 · 2023: 932 · 2022: 880 · 2021: 734 · 2020: 686 · 2019: 420 · 2018: 295 · 2017: 193 · 2016: 87 · 2015: 3
- FWCI
- 25.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Movement Disorders (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- DZNE Pub (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Parkinson's disease, diagnostic criteria, Movement Disorder Society criteria, parkinsonism, bradykinesia, resting tremor, rigidity, non-motor symptoms, prodromal Parkinson's disease, exclusion criteria, diagnostic certainty, diagnosis
- MeSH terms
- Humans, Neuropsychological Tests, Parkinson Disease, Reference Standards, Severity of Illness Index, Societies, Scientific
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
